[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2080855T3 - Pirido-oxacinas sustituidas. - Google Patents

Pirido-oxacinas sustituidas.

Info

Publication number
ES2080855T3
ES2080855T3 ES91111273T ES91111273T ES2080855T3 ES 2080855 T3 ES2080855 T3 ES 2080855T3 ES 91111273 T ES91111273 T ES 91111273T ES 91111273 T ES91111273 T ES 91111273T ES 2080855 T3 ES2080855 T3 ES 2080855T3
Authority
ES
Spain
Prior art keywords
substituted
oxacinas
pirido
lipoproteinaemia
hyperlipoproteinaemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91111273T
Other languages
English (en)
Inventor
Walter Dr Hubsch
Rolf Dr Angerbauer
Peter Dr Fey
Hilmar Dr Bischoff
Joachim Dr Bender
Delf Dr Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2080855T3 publication Critical patent/ES2080855T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE PUEDEN FABRICAR PIRIDO-OXAZINAS SUBSTITUIDAS MEDIANTE REDUCCION DE LAS CETONAS CORRESPONDIENTES. SON SUBSTANCIAS ACTIVAS VALIOSAS EN MEDICAMENTOS, ESPECIALMENTE PARA EL TRATAMIENTO DE HIPERLIPOPROTEINEMIA, LIPOPROTEINEMIA Y ARTERIOSCLEROSIS.
ES91111273T 1990-07-21 1991-07-06 Pirido-oxacinas sustituidas. Expired - Lifetime ES2080855T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4023308A DE4023308A1 (de) 1990-07-21 1990-07-21 Substituierte pyrido-oxazine

Publications (1)

Publication Number Publication Date
ES2080855T3 true ES2080855T3 (es) 1996-02-16

Family

ID=6410808

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91111273T Expired - Lifetime ES2080855T3 (es) 1990-07-21 1991-07-06 Pirido-oxacinas sustituidas.

Country Status (9)

Country Link
US (1) US5137881A (es)
EP (1) EP0468258B1 (es)
JP (1) JPH04305581A (es)
AT (1) ATE129712T1 (es)
CA (1) CA2047327A1 (es)
DE (2) DE4023308A1 (es)
DK (1) DK0468258T3 (es)
ES (1) ES2080855T3 (es)
GR (1) GR3017967T3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9223371D0 (en) * 1992-11-06 1992-12-23 Ici Plc Heterocyclic compounds
DE4244029A1 (de) * 1992-12-24 1994-06-30 Bayer Ag Neue substituierte Pyridine
AR008789A1 (es) 1996-07-31 2000-02-23 Bayer Corp Piridinas y bifenilos substituidos
US7371759B2 (en) 2003-09-25 2008-05-13 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors and method
US7420059B2 (en) 2003-11-20 2008-09-02 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors and method
US9133212B1 (en) 2005-06-15 2015-09-15 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation
US8367669B2 (en) * 2005-06-15 2013-02-05 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE397044C (de) * 1923-05-15 1924-06-25 Leveugle Freres Soc Wasserrohrkessel mit zwei nebeneinanderliegenden Dampf- und Wassersammlern
US3838120A (en) * 1972-12-07 1974-09-24 Sterling Drug Inc 1-alkyl-1h,4h-pyrido(2,3-d)(1,3)oxazine-2,4-diones and their conversion to 1-alkyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids
US4518602A (en) * 1982-10-07 1985-05-21 Takeda Chemical Industries, Ltd. Vinyl carboxylic acid derivatives, their production and use as inhibitors of thromboxane synthetase
US4874775A (en) * 1985-06-11 1989-10-17 Eli Lilly And Company Agriculturally useful sulfonamides
DK277388A (da) * 1987-05-22 1988-11-23 Squibb & Sons Inc Phosphorholdige hmg-coa-reduktase-inhibitorer, mellemprodukter og fremgangsmaade
JPH02237988A (ja) * 1988-11-18 1990-09-20 Nissan Chem Ind Ltd イソオキサゾロピリジン系メバロノラクトン類

Also Published As

Publication number Publication date
EP0468258A1 (de) 1992-01-29
EP0468258B1 (de) 1995-11-02
JPH04305581A (ja) 1992-10-28
ATE129712T1 (de) 1995-11-15
GR3017967T3 (en) 1996-02-29
DK0468258T3 (da) 1996-02-26
DE59106803D1 (de) 1995-12-07
US5137881A (en) 1992-08-11
DE4023308A1 (de) 1992-01-23
CA2047327A1 (en) 1992-01-22

Similar Documents

Publication Publication Date Title
IT1206305B (it) N-aril-ossazolidinoni, -ossazolidintioni, -pirrolidinoni, -pirrolidine e -tiazolidinoni, loro procedimento di preparazione eloro applicazione in terapia.
IT9067125A0 (it) Protesi valvolare cardiaca
NO910923L (no) Trifunksjonell antistofflignende forbindelse som et kombinert diagnostisk og terapeutisk middel.
DE69105462D1 (de) Desinfizierende Zusammensetzung.
NO911934L (no) Fremgangsmaate for fremstilling av bicykliske 1-aza-cykloalkaner.
NO904595L (no) Fremgangsmaate for potensiering av den analgetiske effekt av curcuminoider.
ATE11547T1 (de) Neue d-homosteroide, ihre verwendung und herstellung, sowie pharmazeutische praeparate damit.
NO911429L (no) Stoffbehandling.
ES2058343T3 (es) Piridinas disubstituidas.
ATE129712T1 (de) Substituierte pyrido-oxazine.
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
NO911430D0 (no) Stoffbehandlingsmetode.
DE58909244D1 (de) Verwendung von 1,4-Dihydropyridin-Derivaten in der Behandlung von Alkoholsucht.
FI961339A (fi) Triaryylieteenijohdannaiset käytettäväksi hoidossa
NL7710232A (nl) Kast voor medische, in het bijzonder tandheel- kundige instrumenten.
DE69103824D1 (de) Patientenliegetische.
DE59101256D1 (de) Gleiskörper.
DE69113570D1 (de) Behandlungsmittel.
FI904885A (fi) Registreringsanordning foer idrottsprestationer, speciellt foer haendelsefoerloppet i lagspel.
PT70177A (de) 3,4-dihydroxyzimtaldehydderivat dessen herstellung und arzneimittel
NO905643D0 (no) Fremgangsmaate for behandling av manganslam.
ES1014986Y (es) Cerrojo perfeccionado.
ES1013792Y (es) Cerrojo perfeccionado.
IT9067336A0 (it) Protesi valvolare cardiaca
FI905784A (fi) Anordning foer medicinsk anvaendning.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 468258

Country of ref document: ES